Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metabolomic prediction of diabetes and cardiovascular risk.

Literature DB >> 22710603

Metabolomic prediction of diabetes and cardiovascular risk.

Samuel Dagogo-Jack¹.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 22710603 PMCID： PMC3746061 DOI： 10.1159/000339203

Source DB: PubMed Journal: Med Princ Pract ISSN： 1011-7571 Impact factor: 1.927

× No keyword cloud information.

10 in total

Review 1. Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk.

Authors: Samuel Dagogo-Jack; Nonso Egbuonu; Chimaroke Edeoga
Journal: Med Princ Pract Date: 2010-03-29 Impact factor: 1.927

2. Metabolite profiles and the risk of developing diabetes.

Authors: Thomas J Wang; Martin G Larson; Ramachandran S Vasan; Susan Cheng; Eugene P Rhee; Elizabeth McCabe; Gregory D Lewis; Caroline S Fox; Paul F Jacques; Céline Fernandez; Christopher J O'Donnell; Stephen A Carr; Vamsi K Mootha; Jose C Florez; Amanda Souza; Olle Melander; Clary B Clish; Robert E Gerszten
Journal: Nat Med Date: 2011-03-20 Impact factor: 53.440

3. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans.

Authors: Eugene P Rhee; Susan Cheng; Martin G Larson; Geoffrey A Walford; Gregory D Lewis; Elizabeth McCabe; Elaine Yang; Laurie Farrell; Caroline S Fox; Christopher J O'Donnell; Steven A Carr; Ramachandran S Vasan; Jose C Florez; Clary B Clish; Thomas J Wang; Robert E Gerszten
Journal: J Clin Invest Date: 2011-03-14 Impact factor: 14.808

Review 4. Preventing diabetes mellitus in developing countries.

Authors: Justin B Echouffo-Tcheugui; Samuel Dagogo-Jack
Journal: Nat Rev Endocrinol Date: 2012-04-10 Impact factor: 43.330

5. Metabolite profiling identifies pathways associated with metabolic risk in humans.

Authors: Susan Cheng; Eugene P Rhee; Martin G Larson; Gregory D Lewis; Elizabeth L McCabe; Dongxiao Shen; Melinda J Palma; Lee D Roberts; Andre Dejam; Amanda L Souza; Amy A Deik; Martin Magnusson; Caroline S Fox; Christopher J O'Donnell; Ramachandran S Vasan; Olle Melander; Clary B Clish; Robert E Gerszten; Thomas J Wang
Journal: Circulation Date: 2012-04-11 Impact factor: 29.690

6. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss.

Authors: Blandine Laferrère; David Reilly; Sara Arias; Nicholas Swerdlow; Prakash Gorroochurn; Baani Bawa; Mousumi Bose; Julio Teixeira; Robert D Stevens; Brett R Wenner; James R Bain; Michael J Muehlbauer; Andrea Haqq; Lillian Lien; Svati H Shah; Laura P Svetkey; Christopher B Newgard
Journal: Sci Transl Med Date: 2011-04-27 Impact factor: 17.956

7. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance.

Authors: Christopher B Newgard; Jie An; James R Bain; Michael J Muehlbauer; Robert D Stevens; Lillian F Lien; Andrea M Haqq; Svati H Shah; Michelle Arlotto; Cris A Slentz; James Rochon; Dianne Gallup; Olga Ilkayeva; Brett R Wenner; William S Yancy; Howard Eisenson; Gerald Musante; Richard S Surwit; David S Millington; Mark D Butler; Laura P Svetkey
Journal: Cell Metab Date: 2009-04 Impact factor: 27.287

8. Glucoregulatory physiology in subjects with low-normal, high-normal, or impaired fasting glucose.

Authors: Samuel Dagogo-Jack; Hasan Askari; Gunjan Tykodi
Journal: J Clin Endocrinol Metab Date: 2009-03-10 Impact factor: 5.958

9. Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?

Authors: Xinjie Zhao; Andreas Peter; Jens Fritsche; Michaela Elcnerova; Andreas Fritsche; Hans-Ulrich Häring; Erwin D Schleicher; Guowang Xu; Rainer Lehmann
Journal: Am J Physiol Endocrinol Metab Date: 2008-12-09 Impact factor: 4.310

10. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity.

Authors: Oded Shaham; Ru Wei; Thomas J Wang; Catherine Ricciardi; Gregory D Lewis; Ramachandran S Vasan; Steven A Carr; Ravi Thadhani; Robert E Gerszten; Vamsi K Mootha
Journal: Mol Syst Biol Date: 2008-08-05 Impact factor: 11.429

10 in total

7 in total

Metabolomic prediction of diabetes and cardiovascular risk.

Review 1. Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk.

2. Metabolite profiles and the risk of developing diabetes.

3. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans.

Review 4. Preventing diabetes mellitus in developing countries.

5. Metabolite profiling identifies pathways associated with metabolic risk in humans.

6. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss.

7. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance.

8. Glucoregulatory physiology in subjects with low-normal, high-normal, or impaired fasting glucose.

9. Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?

10. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity.

1. Exploring Factors Associated with Depression and Anxiety among Hospitalized Patients with Type 2 Diabetes Mellitus.

Review 2. Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications.

Review 3. Systems analysis and the prediction and prevention of Type 2 diabetes mellitus.

4. Metabolic syndrome is associated with atrial electrical and mechanical dysfunction.

Review 5. Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium.

6. Quantitative Assessment of Serum Amino Acids and Association with Early-Onset Coronary Artery Disease.

7. Is β-thalassaemia minor associated with metabolic disorder?